BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 20832972)

  • 1. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes.
    Abe T; Shinohara N; Muranaka M; Sazawa A; Maruyama S; Osawa T; Harabayashi T; Kubota K; Matsuno Y; Shibata T; Toyada Y; Shinno Y; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
    Eur J Surg Oncol; 2010 Nov; 36(11):1085-91. PubMed ID: 20832972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of lymph-node dissection in the treatment of upper urinary tract cancer: a multi-institutional study.
    Abe T; Shinohara N; Harabayashi T; Sazawa A; Ishikawa S; Kubota K; Matsuno Y; Osawa T; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Takeuchi I; Kumagai A; Mori T; Togashi M; Nonomura K
    BJU Int; 2008 Aug; 102(5):576-80. PubMed ID: 18410428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density.
    Bolenz C; Shariat SF; Fernández MI; Margulis V; Lotan Y; Karakiewicz P; Remzi M; Kikuchi E; Zigeuner R; Weizer A; Montorsi F; Bensalah K; Wood CG; Roscigno M; Langner C; Koppie TM; Raman JD; Mikami S; Michel MS; Ströbel P
    BJU Int; 2009 Feb; 103(3):302-6. PubMed ID: 18990164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.
    Roscigno M; Cozzarini C; Bertini R; Scattoni V; Freschi M; Da Pozzo LF; Briganti A; Gallina A; Capitanio U; Colombo R; Giorgio G; Montorsi F; Rigatti P
    Eur Urol; 2008 Apr; 53(4):794-802. PubMed ID: 18207313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
    Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Sun M; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Jan; 75(1):118-24. PubMed ID: 19864000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-operative recurrence patterns of urothelial tumors in the upper urinary tract: comparison between renal pelvic and ureteral tumors].
    Sengiku A; Nishiyama H; Shimizu T; Watabe J; Soda T; Kamba T; Yoshimura K; Kanematsu A; Nakamura E; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2008 Nov; 54(11):703-9. PubMed ID: 19068723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.
    Roscigno M; Shariat SF; Freschi M; Margulis V; Karakiewizc P; Suardi N; Remzi M; Zigeuner R; Bolenz C; Kikuchi E; Weizer A; Bensalah K; Sagalowsky A; Koppie TM; Raman J; Fernández M; Ströbel P; Kabbani W; Langner C; Wheat J; Guo CC; Kassouf W; Haitel A; Wood CG; Montorsi F
    Urology; 2009 Nov; 74(5):1070-4. PubMed ID: 19883824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
    BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    Urology; 2007 Feb; 69(2):265-9. PubMed ID: 17320661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy.
    Childs MA; Wood CG; Spiess PE; Debiane LG; Hernandez M; Matin SF; Millikan RE; Siefker-Radtkie A; Scott SM; Pisters LL
    Can J Urol; 2010 Jun; 17(3):5184-9. PubMed ID: 20566011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
    J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy.
    Muramaki M; Miyake H; Terakawa T; Kusuda Y; Fujisawa M
    Urology; 2011 Dec; 78(6):1443.e7-12. PubMed ID: 21924460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
    Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
    World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of regional lymphadenectomy in accordance with primary tumor location on laparoscopic nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study.
    Abe T; Takada N; Matsumoto R; Osawa T; Sazawa A; Maruyama S; Tsuchiya K; Harabayashi T; Minami K; Nagamori S; Hatanaka KC; Tanaka Y; Shinohara N; Nonomura K
    J Endourol; 2015 Mar; 29(3):304-9. PubMed ID: 25255401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience.
    Mason RJ; Kassouf W; Bell DG; Lacombe L; Kapoor A; Jacobsen N; Fairey A; Izawa J; Black P; Tanguay S; Chin J; So A; Lattouf JB; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Fradet Y; Rendon RA
    Urology; 2012 Apr; 79(4):840-5. PubMed ID: 22365453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival.
    Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Nakazawa H; Ito F; Tanabe K
    Int J Urol; 2010 Oct; 17(10):848-54. PubMed ID: 20812922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
    Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
    World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node dissection in renal cell carcinoma.
    Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
    Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.